MedTrace Logo

The MentalPlus® for Assessment and Rehabilitation of Cognitive Function After Remission of the Symptoms of COVID-19

NCT04632719 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2024-03-07

No results posted yet for this study

Summary

This study evaluates and rehabilitates the cognitive functions of attention, memory, visual perception, language, and executive by the mentalPlus® digital game of COVID-19 surviving patients after remission of symptoms.

Conditions

Interventions

DEVICE

The use of the MentalPlus® digital game for assessment and rehabilitation of cognitive function after remission of the symptoms of COVID-19

Cognitive assessment and rehabilitation will be carried out on volunteers who have healed from COVID-19.

Sponsors & Collaborators

  • University of Sao Paulo

    lead OTHER

Principal Investigators

  • Livia S. Valentin, Ph.D · University of Sao Paulo School of Medicine

  • Luiz Antonio M Cesar, Ph.D · University of Sao Paulo School of Medicine

  • Luiz Aparecido Bortolotto, Ph.D · University of Sao Paulo School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
8 Years
Max Age
88 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-11-08
Primary Completion
2020-12-29
Completion
2023-12-29

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04632719 on ClinicalTrials.gov